17-OH Progesterone (17-OHP) Test
17-hydroxyprogesterone is a steroid precursor in cortisol synthesis. Its main diagnostic use is screening for 21-hydroxylase deficiency, the most common form of congenital adrenal hyperplasia (CAH), and evaluating selected patients with androgen excess.
Congenital adrenal hyperplasia and androgen excess
1 Parameter
Serum (2 mL)
6 Hours
Preparation & Fasting Guidelines
When Should You Get Tested?
Detailed Clinical Overview
17-hydroxyprogesterone (17-OHP) is an intermediate steroid metabolite synthesised in the adrenal cortex from progesterone during cortisol biosynthesis. The enzyme 21-hydroxylase converts 17-OHP to 11-deoxycortisol. When 21-hydroxylase is deficient, 17-OHP accumulates in excess and is shunted into adrenal androgen synthesis pathways.
21-hydroxylase deficiency accounts for over 90–95% of all cases of Congenital Adrenal Hyperplasia (CAH). In severe 'classic' CAH, newborns present with life-threatening salt-wasting crises and ambiguous genitalia. In 'non-classic' CAH (NCAH), presentation is delayed until adolescence or adulthood with symptoms mimicking PCOS: hirsutism, persistent acne, irregular menses, and subfertility.
A morning baseline 17-OHP blood test serves as the primary screening investigation to rule out late-onset non-classic CAH in young women presenting with clinical hyperandrogenism.
Clinical Significance
In non-pregnant reproductive-age women, early morning follicular 17-OHP < 200 ng/dL (6 nmol/L) reliably excludes non-classic CAH. Basal levels > 1000 ng/dL are diagnostic, while values between 200 and 1000 ng/dL warrant an ACTH (Cosyntropin) stimulation test.
Diagnostic Limitations & Interferences
- Gestational age and birth weight adjustments are critical in premature neonates.
- Cross-reactivity with other sulfated steroids can produce false-positive immunoassay elevations; LC-MS/MS offers definitive confirmatory specificity.
- A borderline value must never be labelled CAH without Cosyntropin stimulation confirmation.
- Luteal phase collection produces physiological elevations from the corpus luteum, causing diagnostic confusion.
- Exogenous glucocorticoid treatment rapidly suppresses 17-OHP concentrations.
Why Get Tested at QXL Diagnostics?
Reference Ranges — 17-OH Progesterone (17-OHP) Test
NABL-validated intervals · Adults · values may vary by age & sex
| Parameter / Group | Range | Unit | Status |
|---|---|---|---|
| Adult Females (Follicular Phase)Baseline screening window | 15 – 70 | ng/dL | Normal |
| Adult Females (Luteal Phase)Luteal ovarian synthesis | 35 – 290 | ng/dL | Normal |
| Non-Classic CAH Suspicion WindowIndicates ACTH stimulation test | 200 – 1000 | ng/dL | Borderline |
| Adult MalesStandard male reference interval | 27 – 199 | ng/dL | Normal |
⚕️ Reference ranges are population-based guidelines. Results must be interpreted in clinical context by a qualified physician. Always consult your doctor before making healthcare decisions.
Frequently Asked Questions
Q: What condition is 17-OHP mainly used to detect?
A: It is primarily used to screen for 21-hydroxylase deficiency, including classic congenital adrenal hyperplasia in infants and late-onset non-classic CAH in adolescent and adult women.
Q: Why is early-morning testing used?
A: 17-OHP secretion follows the diurnal rhythm of ACTH and cortisol, peaking in the morning hours. Standardised morning timing is essential for reproducible cut-off evaluation.
Q: Can PCOS and non-classic CAH look similar?
A: Yes. Both conditions present with hirsutism, acne, and irregular menstrual cycles. 17-OHP testing separates the two, which is critical because their treatment regimens differ fundamentally.
Q: Does a borderline 17-OHP mean CAH?
A: No. Borderline values (200–1000 ng/dL) require an ACTH stimulation test to evaluate stimulated adrenal capacity before a diagnosis can be established.
Q: Can pregnancy or cycle phase affect the result?
A: Yes. The placenta produces 17-OHP during pregnancy, and the corpus luteum elevates it during the luteal phase. In cycling women, testing must occur during days 1–3 of menses.
Q: Can the assay method matter?
A: Yes. Immunoassays can suffer cross-reactivity with structurally related steroid precursors. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides the highest specificity.
When Should a Patient Seek Urgent Medical Care?
Urgent care is determined by symptoms, not by waiting for a laboratory report. Seek immediate medical assessment for severe vomiting, dehydration, lethargy, or collapse in infants (suspected salt-wasting crisis) or severe acute illness in adults. A laboratory test page must never delay emergency care.
⚠️ Urgent care is determined by symptoms, not by waiting for a laboratory report. A laboratory test page must never delay emergency care.
Evidence Base & Clinical Guidelines
- •Tietz Clinical Guide to Laboratory Tests, 4th ed. Alan H. B. Wu, PhD, DABCC, FACB. W.B. Saunders/Elsevier, 2006.
- •Endocrine Society Clinical Practice Guideline: Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency (J Clin Endocrinol Metab 2018).
Global Medical Disclaimer
This page is for patient education and search/AI information retrieval. It does not diagnose disease, replace a clinical examination, or override the reference interval and interpretive comment on the patient's own laboratory report. Reference intervals, decision limits, specimen requirements and assay interferences can differ by method, age, sex, pregnancy status, clinical setting and laboratory platform. Results must be interpreted with symptoms, examination, medicines, imaging and other investigations.
Includes free doorstep home sample collection
Book Home Collection →Or call: +91 9964 639 639MD (Medical Biochemistry), Consultant Biochemist - 25 years of experience · Congenital adrenal hyperplasia and androgen excess
Non-classic congenital adrenal hyperplasia affects up to 1 in 200 women with hirsutism and is frequently misdiagnosed as routine PCOS. A single morning 17-OHP test during the early follicular phase readily identifies these patients, allowing targeted glucocorticoid therapy rather than empirical treatments.
Clinically reviewed · November 2026 · QXL Diagnostics NABL Lab
NABL Quality Guarantees
NABL Accredited (MC-6849)
ISO 15189:2022 — Medical laboratories — Requirements for quality and competence quality compliance
Same-Day Digital Reports
Delivered straight to WhatsApp & Email
Free Doorstep Collection
Sterile vacuum containers & cold-chain kits
